B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medipharm Labs Corp (OP: MEDIF )

0.0511 -0.0008 (-1.54%)
Streaming Delayed Price Updated: 3:59 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medipharm Labs Corp

< Previous 1 2 3 4 Next >
CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024... 
Via Benzinga
MEDIF Stock Earnings: MediPharm Labs Reported Results for Q2 2024
MediPharm Labs just reported results for the second quarter of 2024. 
Via InvestorPlace
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report- Monday, Aug 12
The past, present and future of the Canadian cannabis sector. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024,... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
MEDIF Stock Earnings: MediPharm Labs Reported Results for Q1 2024
MediPharm Labs just reported results for the first quarter of 2024. 
Via InvestorPlace
Executive Changes In Cannabis Industry You Should Know About, New Appointments & More
Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, who has been serving at cannabis edibles producer Wana Brands since 2022 as... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method
Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'
Via Benzinga
The Canadian Cannabis Report - Monday, April 22
The past, present and future of the Canadian cannabis sector, based on the performanceof the MCCCI, which is a proprietary index of 14 stocks. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
MEDIF Stock Earnings: MediPharm Labs Reported Results for Q4 2023
MediPharm Labs just reported results for the fourth quarter of 2023. 
Via InvestorPlace
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,... 
Via Benzinga
The Canadian Cannabis Report - Monday, March 25
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 14 stocks 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil
Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products... 
Via Benzinga
Topics Cannabis
Exposures Cannabis Product Safety
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of... 
Via Benzinga
New Cannabis Products Energize Global Health & Wellness Market, Including Australia
In the ever-evolving world of cannabis products, innovation is the name of the game for those in search of health and wellness solutions. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve a claim in connection with a commercial agreement dis 
Via Benzinga
New CBD & THC Cannabis Oils Now Shipping To Australia From Canada
MediPharm Labs Corp. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Sept. 25
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietarey index of 15 stocks. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C. 
Via Benzinga
Could Medical Cannabis Be The Answer For Fibromyalgia? Here's What New Study Found
New research has shown that medical cannabis may effectively manage fibromyalgia and associated symptoms of depression and anxiety. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From August 24, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For August 23, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabinoid-Focused Pharma Stock Slides On Q2 Earnings Report, Here Are The Details
Cannabinoid-focused pharmaceutical company MediPharm Labs Corp. 
Via Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For August 15, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From August 14, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From August 11, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For August 10, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.